J.P. Morgan downgraded PVH Corp (NYSE:PVH) to "Neutral" on a slower-than-expected recovery in topline growth amid global macroeconomic challenges and foreign exchange pressures.

The move is the latest recruiting win for RBC Wealth Management as it continues to lure top talent away from big banks and ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

J.P. Morgan analyst Ranjan Sharma maintained a Buy rating on Grab (GRAB – Research Report) on January 21 and set a price target of $5.60. The ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...

Jamie Dimon, chairman and CEO, noted in the release that in the asset and wealth management division client net inflows ...

J.P. Morgan analyst Mark Strouse maintained a Hold rating on Bloom Energy (BE – Research Report) yesterday and set a price target of $16.00.

Cautious Optimism for Deal Making. The general consensus is that we will likely see an increase in M&A and capital market transactions in the ...

The Westin St. Francis Hotel in Union Square will once again be host for one of the biggest conventions in the city--the J.P.

Investing.com -- J.P. Morgan analysts have upgraded their rating for Aviva plc (LON: AV) to "overweight" from "neutral," ...

Dozens of Massachusetts biotech leaders will be heading to San Francisco this upcoming week for the 2025 J.P. Morgan ...